Stefansson, O. A., Hilmarsdottir, H., Olafsdottir, K., Tryggvadottir, L., Sverrisdottir, A., Johannsson, O. T., . . . Sigurdsson, S. (2019). BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy. JNCI Cancer Spectr.
Styl ChicagoStefansson, Olafur A., Holmfridur Hilmarsdottir, Kristrun Olafsdottir, Laufey Tryggvadottir, Asgerdur Sverrisdottir, Oskar T. Johannsson, Jon G. Jonasson, Jorunn E. Eyfjord, a Stefan Sigurdsson. "BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy." JNCI Cancer Spectr 2019.
Citace podle MLAStefansson, Olafur A., et al. "BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy." JNCI Cancer Spectr 2019.